These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4989755)

  • 1. [Ocular changes in long-term treatment with Largactil].
    Kalberer M; Atar Z; Bider E
    Ophthalmologica; 1970; 161(2):118-24. PubMed ID: 4989755
    [No Abstract]   [Full Text] [Related]  

  • 2. Some iatrogenic ocular diseases from systemically administered drugs.
    Bernstein HN
    Int Ophthalmol Clin; 1970; 10(3):553-619. PubMed ID: 4933547
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolonged treatment of psychotic states. (Over 1600 patients treated continuously 3 to 7 years).
    Goldman D
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:51-7. PubMed ID: 4970486
    [No Abstract]   [Full Text] [Related]  

  • 4. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract]   [Full Text] [Related]  

  • 5. Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study.
    Prien RF; DeLong SL; Cole JO; Levine J
    Arch Gen Psychiatry; 1970 Nov; 23(5):464-8. PubMed ID: 5478574
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ocular involvement during prolonged treatment with neuroleptics].
    Nouri A; Cuendet JF
    Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196
    [No Abstract]   [Full Text] [Related]  

  • 7. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 159(1):31-8. PubMed ID: 4984273
    [No Abstract]   [Full Text] [Related]  

  • 8. Ocular side effects of indomethacin.
    Palimeris G; Koliopoulos J; Velissaropoulos P
    Ophthalmologica; 1972; 164(5):339-53. PubMed ID: 4537509
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ocular complications in long-term chlorpromazine treatment].
    Klíma M; Klímová A
    Cesk Oftalmol; 1977 Sep; 33(5):349-52. PubMed ID: 922908
    [No Abstract]   [Full Text] [Related]  

  • 10. Ocular examinations in outpatients given long-term chlorpromazine therapy.
    Sarin LK; Leopold IH; Winkelman NW
    JAMA; 1966 Nov; 198(7):789-90. PubMed ID: 5953346
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous and ocular changes associated with the use of chlorpromazine.
    Wolf ME; Richer S; Berk MA; Mosnaim AD
    Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular changes associated with long term phenothiazine usage.
    Alexander TA; John JK; Thomas A; Verghese A
    Indian J Ophthalmol; 1985; 33(1):27-31. PubMed ID: 2867036
    [No Abstract]   [Full Text] [Related]  

  • 13. Ocular and cutaneous side effects after prolonged chlorpromazine treatment.
    Gombos GM; Yarden PE
    Am J Psychiatry; 1967 Jan; 123(7):872-4. PubMed ID: 6016858
    [No Abstract]   [Full Text] [Related]  

  • 14. Chlorpromazine-induced anterior segment changes.
    Brooks JG; Matoba AY
    Arch Ophthalmol; 1992 Jan; 110(1):126. PubMed ID: 1731707
    [No Abstract]   [Full Text] [Related]  

  • 15. Eye changes in connection with neuroleptic treatment especially concerning phenothiazines and thioxanthenes.
    Edler K; Gottfries CG; Haslund J; Ravn J
    Acta Psychiatr Scand; 1971; 47(4):377-84. PubMed ID: 5146713
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenothiazines and eye complications.
    Valentine M; Jardine P
    Br Med J; 1966 Sep; 2(5513):586. PubMed ID: 5917372
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced macular disease.
    Potts AM
    Trans Am Acad Ophthalmol Otolaryngol; 1966; 70(6):1054-7. PubMed ID: 5971468
    [No Abstract]   [Full Text] [Related]  

  • 18. Incidence and significance of chlorpromazine-induced eye changes.
    De Long SL
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741
    [No Abstract]   [Full Text] [Related]  

  • 19. Ocular melanosis with special reference to chlorpromazine.
    Cameron ME
    Br J Ophthalmol; 1967 May; 51(5):295-305. PubMed ID: 6022771
    [No Abstract]   [Full Text] [Related]  

  • 20. Progressive generalized cone dysfunction.
    François J; de Rouck A; Verriest G; de Laey JJ; Cambie E
    Ophthalmologica; 1974; 169(4):255-84. PubMed ID: 4547582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.